Edward Robert Scheffer Cliff

40PUBLICATIONS
117CO-AUTHORS
Haematological tumoursAutoimmunityCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 14, 2026
Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma.

|Jun 15, 2026
Immunosuppression-Associated Peripheral T-Cell Lymphoma.

|Jun 08, 2026
Does ciltacabtagene autoleucel have a future in multiple myeloma?

|Mar 23, 2026
Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era.

Edward R Scheffer Cliff, Sean McKeague, Michael J Dickinson

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

Pageof 7

Frequent Collaborators

11 joint publications

Ghulam Rehman Mohyuddin

6 joint publications

Rajshekhar Chakraborty

5 joint publications

Aaron S Kesselheim

5 joint publications

David A Russler-Germain